Prime Medicine, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +529.9% | +451.0% | +19.4% | -46.2% | +53.5% | +15.2% | |
| – | +514.0% | +406.7% | +9.6% | -51.8% | +48.2% | -14.4% | |
| – | +327.6% | +401.5% | +1.2% | -77.8% | +338.9% | -65.5% | |
| – | +516.7% | +405.6% | +9.0% | -58.6% | +56.5% | -6.7% | |
| – | – | +2,530.5% | +21.2% | – | – | – | |
| – | +191.6% | +192.3% | -29.3% | +38.0% | +137.5% | +53.7% | |
| – | +166.0% | +198.2% | -53.9% | +111.2% | -32.7% | -1.4% | |
| – | – | -58.1% | +59.4% | -20.7% | -61.0% | +125.2% | |
| – | – | +474.0% | +201.9% | +351.0% | -41.9% | -21.7% | |
| – | +2,309.9% | +615.7% | +32.0% | -57.9% | +15.1% | -21.1% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +1.5% | -6.4% | +30.4% | +25.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.